Target intelligence / Profile preview

Kelch-like protein 11 (KLHL11)

Target
KLHL11
Molecular classification
E3 ubiquitin ligase adapter (BTB-CUL3-RBX1 complex), Scaffold protein (Kelch domain superfamily), Other (BTB/POZ domain-containing protein)
01

Overview

Kelch-like protein 11 (KLHL11) is a member of the KLHL family of proteins, which are characterized by the presence of BTB/POZ, BACK, and Kelch domains that facilitate scaffolding and protein–protein interactions[1][4]. KLHL11 serves as a substrate-specific adapter for cullin-3–based E3 ubiquitin ligase complexes, promoting the ubiquitination and subsequent degradation of target proteins[4]. Members of this protein family are evolutionarily conserved and play important roles in cellular processes including actin cytoskeleton organization, protein turnover, and regulation of intracellular signaling pathways[1][2]. Mutations in certain KLHL family proteins, including KLHL11, have been implicated in Mendelian diseases and various cancers, highlighting the clinical significance of this family[1][2]. KLHL11 is the most ancient member of the human KLHL family, and its precise physiological substrates and disease associations remain active areas of research[1][2]. If you are seeking a therapeutic target, KLHL11 is classified as an E3 ubiquitin ligase adapter, but as of now, no drugs are known to directly target it or use it as a primary biomarker. It is a recognized target in molecular and disease studies, especially around cancer[1][2][4].

Other names
KLHL11Kelch-like family member 11
02

Mechanism of action

E3 ubiquitin ligase substrate adapter (mediates ubiquitination and degradation of client proteins via the cullin-3 complex)

03

Biological functions

Ubiquitination of target proteins (mediation of E3 ligase activity)Protein–protein interactions (scaffolding)Intracellular signaling regulation
04

Disease associations

CancerGenetic (Mendelian) diseasesOther (potential roles in neurodegenerative disease, based on E3 ubiquitin ligase implication)

Beyond the preview

Go deeper on Kelch-like protein 11 (KLHL11).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kelch-like protein 11 (KLHL11).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call